A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
- 1 February 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 334 (5), 296-301
- https://doi.org/10.1056/nejm199602013340504
Abstract
Primary pulmonary hypertension is a progressive disease for which no treatment has been shown in a prospective, randomized trial to improve survival.Keywords
This publication has 25 references indexed in Scilit:
- Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous cathetersAmerican Journal Of Medicine, 1991
- Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failureThe American Journal of Cardiology, 1989
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Heart-Lung TransplantationThe New England Journal of Medicine, 1982
- Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.Circulation, 1981
- Control of elevated pulmonary vascular resistance in neonatal swine with prostacyclin (PGI2)Prostaglandins and Medicine, 1979
- An adrenergic participation subserving a positive inotropism and chronotropism of prostacyclin on isolated rat atriaCellular and Molecular Life Sciences, 1979
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- Estimates of Location Based on Rank TestsThe Annals of Mathematical Statistics, 1963